Abbott (ABT)'s investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system is specifically designed to deliver pacing to the left bundle branch area, activating the heart's natural ...

Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...

Philadelphia, February 20, 2025 – Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature.

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.

(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...

iData Research: Global Cardiac Rhythm Management market to hit $36B by 2032. Leadless pacing and pulsed field ablation lead the industry. Pulsed field ablation, and leadless pacing are expanding the ...

The MarketWatch News Department was not involved in the creation of this content. TORTOLA, British Virgin Islands, Feb. 25, 2026 /CNW/ -- Cara Medical Ltd. today announced that the U.S. Food and Drug ...